JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A4496 NSC 3852

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in EtOH; insoluble in H2O; ≥7.35 mg/mL
A8547 Tubastatin A HCl
1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC6 inhibitor,potent and selective

insoluble in EtOH; ≥12.34 mg/mL
A8803 RGFP966
4 Citation

Target: Histone Deacetylases (HDACs)

Summary: Specific HDAC3 inhibitor

insoluble in H2O; ≥18.12 mg/mL
B4890 HPOB
1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC6 inhibitor, potent and selective

≥31.4 mg/mL
B5916 Chidamide
1 Citation

Target: HDAC

Summary: Novel HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥18.55 mg/mL
A8173 Romidepsin (FK228, depsipeptide)
7 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC1/HDAC2 inhibitor, potent and selective

≥27.04 mg/mL
A4083 Rocilinostat (ACY-1215)
1 Citation

Target: Histone Deacetylases (HDACs)

Summary: Selective HDAC6 inhibitor

≥21.675 mg/mL
A4084 Vorinostat (SAHA, MK0683)
9 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL
A4089 Mocetinostat (MGCD0103, MG0103)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,isotype-selective and potent

insoluble in EtOH; insoluble in H2O; ≥19.8 mg/mL
A4090 JNJ-26481585
3 Citation

Target: Histone Deacetylases (HDACs)

Summary: Potent HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥19.2 mg/mL